Skip to main content
. 2019 Aug 1;18(3):513–522.

Table 2.

Vascular and blood characteristics. Values are mean ± standard deviation.

Whole Group Boys Girls
Macrovascular PAI (%) 49.3 ± 9.9 (n=93) 48.2 ± 9.6 (n=50) 50.5 ± 10.2 (n=43)
Carotid to ankle PWV (m.s-1) 5.97 ± 0.46 (n=90) 5.94 ± 0.46 (n=50) 6.02 ± 0.47 (n=40)
Carotid to radial PWV (m.s-1) 6.64 ± 0.74 (n=94) 6.59 ± 0.66 (n=52) 6.70 ± 0.83 (n=42)
Microvascular FMR (V) 1.78 ± 0.37 (n=96) 1.78 ± 0.32 (n=53) 1.79 ± 0.44(n=43)
Peak ACh response (V) 1.96 ± 0.42 (n=93) 1.97 ± 0.46 (n=51) 1.95 ± 0.37 (n=42)
ACh AUC (V x time) 479.6 ± 132.1 (n=92) 488.5 ± 140.2 (n=50) 469.1 ± 122.5 (n=42)
Peak SNP response (V) 1.62 ± 0.49 (n=69) 1.65 ± 0.48 (n=38) 1.59 ± 0.51 (n=31)
SNP AUC (V x time) 285.9 ± 113.6 (n=69) 291.6 ± 112.8 (n=38) 278.9 ± 115.9 (n=31)
Blood Total cholesterol (mmol.L-1) 4.50 ± 0.46 (n=79) 4.53 ± 0.66 (n=49) 4.47 ± 0.47 (n=30)
HDL-C (mmol.L-1) 1.86 ± 0.42 (n=78) 1.89 ± 0.44 (n=49) 1.80 ± 0.39 (n=29)
LDL-C (mmol.L-1) 2.29 ± 0.59 (n=78) 2.28 ± 0.55 (n=49) 2.30 ± 0.66 (n=29)
TG (mmol.L-1) 0.80 ± 0.29 (n=79) 0.77 ± 0.29 (n=49) 0.84 ± 0.30 (n=30)
Glucose (mmol.L-1) 4.33 ± 0.42 (n=80) 4.32 ± 0.40 (n=49) 4.35 ± 0.36 (n=31)
Specific insulin (pmol.L-1) 48.0 ± 25.0 (n=77) 44.2 ± 24.1 (n=46) 53.6 ± 25.6 (n=31)
β-cell function (%) 124.5 ± 45.6 (n=77) 117.4 ± 45.7 (n=46) 135.0 ± 44.1 (n=31)
HOMA-IS (%) 141.2 ± 87.1 (n=77) 153.0 ± 90.1 (n=46) 123.7 ± 80.6 (n=31)
HOMA-IR 0.98 ± 0.51 (n=77) 0.90 ± 0.48 (n=46) 1.09 ± 0.52 (n=31)

Values are mean ± standard deviation. Sample size (n=) is provided for each outcome. PAI - peripheral non-transformed augmentation index; PWV - pulse wave velocity; FMR - functional microvascular reserve; ACh - acetylcholine; AUC - area under the curve; SNP - sodium nitroprusside; HDL-C - high density lipoprotein cholesterol; LDL-C – low density lipoprotein cholesterol; TG -Triglyceride; HOMA – Homeostatic model assessment; IS – Insulin sensitivity; IR – Insulin resistance.